Browsing Category

Supplier News

195 posts

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

2019 VCI Editorial Calendar
By

By
Topics of Discussion: Through expert interviews, discussions, and market analysis, DCAT Value Chain Insights provides need-to-know information to keep pace with a changing marketplace: Market Watch: Tracking the performance of…

Press Release Submission Guidelines
By

By
Editorial Submissions: Press Releases/News Top Industry News, a companion newsletter to DCAT Value Chain Insights, is delivered by DCAT to its members each Friday and reports on the the news…

2021 VCI Editorial Calendar
By

By
Topics of Discussion: Through expert interviews, discussions, and market analysis, DCAT Value Chain Insights provides need-to-know information to keep pace with a changing marketplace: The Global Pharma Watchlist: Tracking the…

Catalent Adds Cell/Gene-Therapy Services with $315-M Buy of MaSTherCell
By

By
  Mike GrippoSenior Vice President, Strategy and Corporate DevelopmentCatalent Pharma Solutions Catalent is increasing its cell-and gene-product development and manufacturing capabilities through its recently completed $315-million acquisition of MaSTherCell, a…

Cambrex CEO Outlines Company’s Growth Strategy
By

By
  Steven KloskCEOCambrex Cambrex is moving forward with a growth plan following the recent sale of the company for $2.4 billion to an affiliate of the investment firm, Permira Funds,…

Thermo Fisher Investing $475 M to Expand Capacity and Capabilities
By

By
  Michael ShaferSenior Vice President and President, Pharma ServicesThermo Fisher Scientific Thermo Fisher Scientific is investing more than $475 million in 2020 in commercial capabilities and capacity for biologics, cell…

WuXi STA Expands Oligo, HPAPI and Peptide Manufacturing in China
By

By
  Yu LuVice President, Business OperationsSTA Pharmaceutical (WuXi STA) WuXi STA is proceeding with a series of investments to expand oligonucleotide, high-potency active pharmaceutical ingredient (API), and peptide manufacturing at…

SK pharmteco Launches Newly Formed CDMO
By

By
  Aslam MalikCEOSK pharmteco SK Holdings, the holding company of South Korea’s SK Group, has launched a new organizational structure and identity for its contract development and manufacturing organization (CDMO)…

Recipharm Begins Integration of $629-M Acquisition of Consort Medical
By

By
  Mark QuickCEO of Consort Medical and Executive Vice President, Corporate DevelopmentRecipharm Recipharm is building its capabilities and scale following the completion of its £505 million ($629 million) acquisition of…

Lonza Updates Plan for New Mammalian Biomanufacturing Facility in China
By

By
  David MaierHead of China Strategic Growth Projects, Mammalian & Microbial Development & ManufacturingLonza AG Lonza is proceeding with plans for a new mammalian biologics development and manufacturing facility in…